Financial Performance - Net sales for Q4 FY2025 decreased by 38.1million,or5.8615.8 million compared to 653.8millionintheprioryearquarter[3]−ForFY2025,netsalesincreasedby29.8 million, or 1.0%, to 2,904.2million,drivenbygrowthintheInfiltratorbusinessandAlliedproductsportfolio[8]−NetsalesforthethreemonthsendedMarch31,2025,were615,761,000, a decrease of 5.8% compared to 653,840,000forthesameperiodin2024[24]Profitability−AdjustedEBITDAforQ4FY2025decreasedby14.5 million, or 7.6%, to 176.7million,representing28.751.7 million, or 4.5%, to 1,094.2million,primarilyduetounfavorablepricingandmaterialcosts[9]−NetincomeattributabletoADSforthethreemonthsendedMarch31,2025,was77,157,000, a decline of 18.7% from 94,822,000intheprioryear[24]−AdjustedEBITDAforthethreemonthsendedMarch31,2025,was176,695, down from 191,178inthesameperiodof2024[38]−NetincomeforthefiscalyearendedMarch31,2025,was452,573, down from 513,291in2024,adeclineof11.8165.6 million to 368.5million,comparedto534.1 million in the prior year[13] - The company reported a net cash provided by operating activities of 581,491,000forthefiscalyearendedMarch31,2025,downfrom717,928,000 in 2024, a decrease of 19.0%[28] - As of March 31, 2025, the company's net debt was 962.3million,anincreaseof101.4 million from the previous year[13] - Long-term debt obligations, net, were 1,251,589,000asofMarch31,2025,comparedto1,259,522,000 in 2024, showing a slight decrease of 0.6%[26] Expenses - Selling, general and administrative expenses for FY2025 increased by 9.7million,or2.6380.4 million, representing 13.1% of sales[10] - Operating expenses for the fiscal year ended March 31, 2025, were 380,378,000,slightlyhigherthan370,714,000 in 2024, reflecting an increase of 2.0%[24] - Interest expense for the fiscal year ended March 31, 2025, was 91,803,slightlyupfrom88,862 in 2024[38] Capital Expenditures - Capital expenditures for the fiscal year ended March 31, 2025, were 212,944,000,comparedto183,812,000 in 2024, an increase of 15.9%[28] - Capital expenditures for the fiscal year ended March 31, 2025, were 212,944,anincreasefrom183,812 in 2024[40] Dividends and Shareholder Returns - The company declared cash dividends of 0.16pershareforthethreemonthsendedMarch31,2025,upfrom0.14 per share in the same period of 2024[24] Acquisition - The company completed the acquisition of Orenco on October 1, 2024, which is expected to enhance its Infiltrator segment[14] Assets - Total assets increased to 3,690,360,000asofMarch31,2025,comparedto3,268,913,000 as of March 31, 2024, representing a growth of 12.9%[26] - Cash and restricted cash at the end of the fiscal year was 469,271,000,downfrom495,848,000 in the previous year, indicating a decrease of 5.4%[28] Earnings Per Share - Diluted earnings per share for the three months ended March 31, 2025, was 0.99,downfrom1.21 in 2024, reflecting a decline of 18.2%[42] - Adjusted earnings per share for the fiscal year ended March 31, 2025, was 5.89,comparedto6.39 in 2024, representing a decrease of 7.8%[42]